More animal studies would be needed to move this drug toward human clinical trials, but «what we hope is that we could use this drug to intervene in patients who have had an
episode of prolonged seizures and give it to them briefly following that
episode to protect them
from becoming
epileptic,» said James McNamara, M.D., a professor in the departments of neurobiology and neurology at Duke University.